ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,288, issued on Oct. 27, was assigned to CIT THERAPEUTICS INC. (La Jolla, Calif.).
"4,5,6,7-tetrahydrothieno[2,3-cpyridine sumo inhibitors and uses thereof" was invented by Xiaohu Ouyang (Rosemead, Calif.), Miles Douglas Kubota (Monrovia, Calif.), Andrew Stewart Tasker (Simi Valley, Calif.), Fang-Tsao Hong (Thousand Oaks, Calif.), Mary Walton (Camarillo, Calif.) and Victor J. Cee (Thousand Oaks, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds and compositions capable of acting as inhibitors of small ubiquitin-like modifier (SUMO) family of proteins. The compounds and compositions may be used in the tre...